Cividini, Federico
- Cardiac Rsk3 Inhibitors, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,632
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,632
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Cividini, Federico as a PI. Multi-PI records show the full award amount for context.
- 1R44HL167349-01A1R44Contact PIRSK3 Anchoring Disruptor Therapy for Heart Failure$2Maward amount
- 5R44HL158318-03R44Contact PIPP2A Anchoring Disruptor Therapy in Heart Failure$1.2Maward amount
Award organization
Organizations that administered FY2023 awards listing Cividini, Federico as a PI.
FY2023 award administered by Cardiac Rsk3 Inhibitors, LLC (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardCardiac Rsk3 Inhibitors, LLC
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #2953
- 2021Entered Top 25% NationallyRanked #2953
- 2022$5M Cumulative Funding
- 2023Entered Top 10% NationallyRanked #1632